4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-20-019337
10% owner bought 475,000 shares at $16.00 ($7,600,000)
- 10% owner acquired 3,538,995 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
New Enterprise Associates 14, L.P. · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-16 | Conversion : show line 1 in the form | +3,538,995 | 3,538,995 | D | ||
| 2020-03-16 | Purchase : show line 2 in the form | +475,000 | $16.00 | $7,600,000 | 4,013,995 | D |
| Open-market purchases · 475,000 sh · avg $16.00 · $7,600,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-16 | Conversion : show line 3 in the form Series Seed Preferred Stock | −1,342,780 | 0 | D |
| 2020-03-16 | Conversion : show line 4 in the form Series A Preferred Stock | −15,323,454 | 0 | D |
| 2020-03-16 | Conversion : show line 5 in the form Series B Preferred Stock | −5,625,926 | 0 | D |
Loading xslF345X03/doc4.xml…